• English
  • Español

newborn solutions

Non-invasive screening for infant meningitis

  • HOME
  • NEOSONICS
  • NEWS
  • TEAM
  • ABOUT US
  • INVESTORS
  • CONTACT

MARTA PRINCEP, PhD, MSC

Business Strategy Director

rita-quesada

HIGHLIGHTS

Marta has built a career of 16 years becoming Head of Central Nervous System Pharmacology department at Ferrer Pharmaceutical company (Spain, 800M€ revenues, 2.000 employees) and leading innovation and research in joint ventures of the group.

Marta holds an Advanced Management Program at ESADE and The Wharton School (University of Pennsylvania) where she mastered in global growth strategy, business opportunities and fiancial challenges.

Her experience was put at the service of the largest Biocluster in Catalunya – Biocat, as Innovation Director and Board Member, to define strategies that foster, leverage and promotes entrepreneurship, technology transfer and public-private investment in the region.

Such vast knowledge and network has brought Marta to become a key contributor of the Catalan Biomedical industry through various responsibility positions at Bellavista Legal, GAEM Foundation, Mind The Byte, and the Richi Foundation and several healthech startups. To our privilege, Marta is Business Strategy director of NBS through company organic and inorganic growth, defining collaborations and know-how protection strategies.

27 years building, transferring and fostering innovation in Pharma, Biotech and public-private institutions.
Know more.

Contact

marta.princep@newborn.solutions

Legal Notice :: Privacy Policy :: Cookie Policy

We partner with El Corriol to power our website and design our branding strategy.

Copyright © 2016 newborn solutions :: Non-invasive screening for infant meningitis